How Viseven’s Digital Content Factory Scaled Biotech Content Creation 

Before the COVID-19 pandemic, a major part of pharmaceutical companies made face-to-face visits their highest priority channel for HCP engagement. And, honestly, this was a fair move since a sales rep call was the most effective strategy to boost prescription intent.  

However, when the quarantine hit, these meetings dropped by 70%. The strategy had to change, and quick, to make sure that a brand doesn’t lose opportunities. 

Content marketing, personalization, and omnichannel distribution surged to the top of priorities list. All of these approaches and strategies were difficult to achieve and succeed in alone, especially because it had to be done fast and well. So life sciences companies needed a reliable partner savvy in their industry, in marketing, and in technology. And Viseven had exactly the required skill set. 

Client Overview 

In 2021, one Belgium-based biotechnology company, specializing in the development and commercialization of innovative drugs, was also searching for a capable pharma content development partner. Having assisted patients worldwide, the company is an industry leader and remains one of the most trusted organizations today.

The biotechnology company wanted to standardize its content delivery process, and produce more relevant and more engaging content for their audience. This meant that they had to create a much bigger volume of content, and deliver it to market fast, while keeping operational costs at bay. 

To achieve these goals, they initiated a Request for Proposal (RFP) for a content factory (CF). And Viseven emerged as the winner among all participants.

Challenge 

Our client aimed to gain a competitive edge in new markets where customers already had strong relationships with local biotechnology companies. Entering these environments required more than visibility — it was necessary to have relevance and credibility.  

The goal of our team was to develop and launch targeted, persuasive content campaigns that would build trust, demonstrate value, and encourage HCPs to reconsider their existing partnerships. 

Solution  

The Viseven team supported the client in building a Digital Content Factory (DCF) designed to produce personalized, meaningful content at scale.  

On this project, our experts implemented a modular content approach to reduce production costs, ensure message consistency, and accelerate the medical, legal, and regulatory (MLR) approval process. We ensured the smooth delivery of content across multiple channels, including e-detailing content production, emails, landing pages, and banners, to engage our target audiences effectively.  

The solution was launched globally in 2021, and, after demonstrating positive results, distributed across all ten markets the client wanted to target. We continue our partnership still to this day. 

What is DCF at Viseven? Viseven DCF is a structured way to produce content without locking teams into a single rigid process. Instead of managing content through scattered tools and one-off requests, the DCF sets up a shared workflow for planning, creating, approving, and reusing content in one system. Our DCF service is flexible and customizable, so teams can pick the model that fits them best, from full service, to partial support, or mostly self-managed creation. 

Our process 

Successful implementation required a strong focus on change management. This included close collaboration with local markets, dedicated liaison managers for each region, structured onboarding, and ongoing communication to ensure alignment and deliver added value. The CF strategy was actively supported by global stakeholders, which helped drive adoption, personalized HCP communication, and consistency across markets. 

Flexibility and readiness to adapt proved essential as the initiative evolved. What began as a CF supporting two channels rapidly expanded into a full-scale Digital Content Factory, encompassing omnichannel initiatives, Adobe Experience Manager (AEM) websites, dedicated delivery teams, eWizard Assisted Services, and multiple projects.  

A robust technology stack, including Veeva CRM & CLM, Veeva Vault PromoMats, Veeva CRM MyInsights, Salesforce Marketing Cloud, and Adobe Experience Manager, supported the solution.

Impact 

By introducing a standardized modular content creation process, the client significantly reduced time-to-market while minimizing errors through the use of pre-tested templates. What was once a fragmented approach evolved into a reliable, repeatable system that teams could confidently scale. 

At the same time, the content ecosystem expanded well beyond its initial scope. Distribution channels expanded from two to five and were fully integrated into a single, coordinated environment, ensuring consistent messaging and a more cohesive experience across all touchpoints. This expansion enabled broader reach and deeper engagement without increasing complexity. 

The results were quickly reflected in demand and stakeholder confidence.

Peak request volumes increased from 28 in 2022 to 217 in 2023, demonstrating rapid adoption and trust in the model. Stakeholder satisfaction remained consistently high, with an average rating of 4.9 out of 5: 

The project is set to continue and scale further. Building on the success of the modular approach, the next phase focuses on expanding this model across additional channels, including applications and eLearning solutions. At the same time, web content will be progressively migrated from Adobe Experience Manager to eWizard, enabling a fully DIY approach and giving markets greater autonomy and speed. One of the most impressive aspects of the collaboration has been the pace and breadth of growth. With Viseven Digital Content Factory, we were able to expand our compliant pharma content workflows. Today, the scope includes omnichannel initiatives, AEM websites, dedicated delivery teams, eWizard Assisted Services, and multiple other projects.

What We Learned 

The key lesson throughout this growth was the importance of flexibility, effective change management, and a trusted partnership — all of which enabled the solution to grow dynamically in response to the client’s evolving needs. Achieving global content scalability, establishing a content factory pharma model, and agile content operations is a challenging task, but not an impossible one. It takes time, preparation, and a lot of planning to create a life sciences content strategy, but with the right team of people by your side, you can do it much faster than anticipated.